Browse by People

Collapse authors list.
Humby, Frances, Durez, Patrick, Buch, Maya H, Lewis, Myles J, Rizvi, Hasan, Rivellese, Felice, Nerviani, Alessandra, Giorli, Giovanni, Mahto, Arti, Montecucco, Carlomaurizio et al (show 20 more authors) , Lauwerys, Bernard, Ng, Nora, Ho, Pauline, Bombardieri, Michele, Romao, Vasco C, Verschueren, Patrick, Kelly, Stephen, Sainaghi, Pier Paolo, Gendi, Nagui, Dasgupta, Bhaskar, Cauli, Alberto, Reynolds, Piero, Canete, Juan D, Moots, Robert ORCID: 0000-0001-7019-6211, Taylor, Peter C, Edwards, Christopher J, Isaacs, John, Sasieni, Peter, Choy, Ernest and Pitzalis, Costantino (2021) Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. LANCET, 397 (10271). pp. 305-317.

Collapse authors list.
Alten, Rieke, Nieto-Gonzalez, Juan Carlos, Jacques, Peggy, Montecucco, Carlomaurizio, Moots, Robert ORCID: 0000-0001-7019-6211, Radner, Helga, Vonkeman, Harald E, Heidenreich, Sebastian, Whichello, Chiara, Krucien, Nicolas et al (show 1 more authors) and Van Beneden, Katrien (2024) What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment. RMD open, 10 (1). e003311-e003311.